BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10897129)

  • 1. Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?
    Sanz MA; Larrea L; Sanz G; Martín G; Sempere A; Gomis F; Martínez J; Regadera A; Saavedra S; Jarque I; Jiménez C; Cervera J; de La Rubia J
    Haematologica; 2000 Jul; 85(7):758-62. PubMed ID: 10897129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid].
    Itoh K; Gotoh W; Yagasaki F; Itoh Y; Kawai N; Matsuda A; Tominaga K; Kusumoto S; Ino H; Murohashi I; Jinnai I; Takeuchi H; Bessho M; Hirashima K
    Rinsho Ketsueki; 1998 Mar; 39(3):221-6. PubMed ID: 9577647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
    Hisatake J; Shimozuma J
    Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
    Zhang T; Westervelt P; Hess JL
    Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
    Avvisati G; Lo Coco F; Mandelli F
    Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
    Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
    Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Sweet syndrome in an acute promyelocyte leukemia patient during treatment with all-trans retinoic acid--case report and literature review].
    Yan ZS; Li DP; Jiang EL; Zhou CL; Liu EB; Chen HS; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):462-5. PubMed ID: 18072629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
    Lederman CA; Weisberger J; Seiter K; Feldman EJ
    Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
    Yang J; Han Z; Pei M; Xiao N
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous infiltration by leukemic cells in acute promyelocytic leukemia of a child after treatment with all-trans retinoic acid.
    Kishimoto S; Ishii E; Murakami Y; Takeshita M; Watanabe M; Sakai R; Miyazaki S
    Pediatr Hematol Oncol; 1997; 14(2):169-75. PubMed ID: 9089745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse.
    Morita Y; Takahashi A; Yamamoto K; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2004 Mar; 149(2):131-6. PubMed ID: 15036889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
    Abe S; Ishikawa I; Harigae H; Sugawara T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
    Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.